Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

363
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
363
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.1K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.8K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.8K
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect01:28

Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect

184
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly...
184
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

208
Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates...
208
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multistationarity questions in reduced versus extended biochemical networks.

Journal of mathematical biology·2024
Same author

Parameter regions that give rise to 2[n/2] +1 positive steady states in the n-site phosphorylation system.

Mathematical biosciences and engineering : MBE·2019
Same author

Identifiability from a Few Species for a Class of Biochemical Reaction Networks.

Bulletin of mathematical biology·2019
Same author

Multistationarity in Structured Reaction Networks.

Bulletin of mathematical biology·2019
Same author

Regions of multistationarity in cascades of Goldbeter-Koshland loops.

Journal of mathematical biology·2018
Same author

MAPK's networks and their capacity for multistationarity due to toric steady states.

Mathematical biosciences·2015
Same journal

A perception-memory PDE framework for seasonal migration dynamics.

Journal of mathematical biology·2026
Same journal

Dynamic resource allocation in eukaryotic Resource Balance Analysis.

Journal of mathematical biology·2026
Same journal

Discrete-time exploitative competition model of different stage-specific predators.

Journal of mathematical biology·2026
Same journal

Spatiotemporal SEIQR Epidemic Modeling with Optimal Control for Vaccination, Treatment, and Social Measures.

Journal of mathematical biology·2026
Same journal

Phenotypic plasticity trade-offs in an age-structured model of bacterial growth under stress.

Journal of mathematical biology·2026
Same journal

Intraspecific interactions facilitate mutualism across multilayer networks under weak selection.

Journal of mathematical biology·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.4K

Implicit dose-response curves.

Mercedes Pérez Millán1, Alicia Dickenstein

  • 1Dto. de Matemática, FCEN, Universidad de Buenos Aires, Ciudad Universitaria, Pab. I, C1428EGA , Buenos Aires, Argentina, mpmillan@dm.uba.ar.

Journal of Mathematical Biology
|July 11, 2014
PubMed
Summary
This summary is machine-generated.

Computational algebraic geometry provides new tools to bound the maximal response of biochemical reaction networks. These improved bounds enhance numerical methods for studying complex biological systems without simulations.

More Related Videos

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

19.7K
Extracellular Multi-Unit Recording from the Olfactory Nerve of Teleosts
07:02

Extracellular Multi-Unit Recording from the Olfactory Nerve of Teleosts

Published on: October 6, 2020

6.6K

Related Experiment Videos

Last Updated: Apr 27, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.4K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

19.7K
Extracellular Multi-Unit Recording from the Olfactory Nerve of Teleosts
07:02

Extracellular Multi-Unit Recording from the Olfactory Nerve of Teleosts

Published on: October 6, 2020

6.6K

Area of Science:

  • Biochemistry
  • Systems Biology
  • Computational Algebraic Geometry

Background:

  • Understanding steady-state dynamics in biochemical networks is crucial for predicting system behavior.
  • Current methods often rely on simulations or explicit analytical solutions, which are not always feasible.
  • Autonomous polynomial dynamical systems describe many biological processes.

Purpose of the Study:

  • To develop novel computational algebraic geometry tools for analyzing steady-state features of polynomial dynamical systems.
  • To derive nontrivial bounds for species concentrations, particularly the output of biochemical reaction networks.
  • To improve the efficiency of numerical methods by providing smaller starting boxes.

Main Methods:

  • Utilizing elimination of variables from computational algebraic geometry.
  • Applying resultants and discriminants to analyze implicitly defined dose-response curves.
  • Developing symbolic computation methods to extract system properties.

Main Results:

  • Obtained nontrivial bounds for steady-state concentrations in mass-action kinetics biochemical networks.
  • Demonstrated application to a sequential enzymatic network, yielding upper bounds for substrate concentrations.
  • Showcased the extraction of information from implicit dose-response curves without simulations or explicit solutions.

Conclusions:

  • The developed algebraic geometry tools offer a powerful, simulation-free approach to analyze biochemical network responses.
  • These methods provide tighter bounds, improving the performance of numerical simulations.
  • The framework is applicable to a broad range of autonomous polynomial dynamical systems beyond enzymatic networks.